DxBooks Data Insights

Blogs

DeciBio Analytics Launches 2021 DxBooks Databases

DeciBio Analytics has launched three 2021 DxBooks databases, covering U.S. labs’ testing behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2 testing. These databases, purchased in 2019

DxBooks Data Insights: 3 Trends in Hospital COVID Testing Since April

  The SARS-CoV-2 DxBook launched in April, during the first few weeks of widespread lockdowns, and the team has diligently collected data on testing behaviors at hospitals around the country

DxBooks Data Insights: Why Large-Scale Antibody Testing Remains Out of Reach

  With its ability to quantify past infections and potential to measure population-level immunity, serology testing adds an attractive tool to the COVID-fighting toolkit. While the initial burst of test

DxBooks Data Insights: Supply-Chain Constraints Hinder Diagnostic Testing Capabilities

  Months into the COVID-19 pandemic, U.S. testing capacity continues to lag behind its goals. The Harvard Global Institute estimated that the U.S should have at least 900,000 SARS-CoV-2 tests

DxBooks Data Insights: Hospital Labs’ Readiness for the Coronavirus Testing Onslaught

  SARS-CoV-2 media attention has largely focused on diagnostic reference labs as they have scaled up testing capacity. However, hospital labs, which drive the vast majority of seasonal respiratory virus